Comparison of the pharmacokinetics and protein binding of the anticancer drug, amsacrine and a new analogue, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenyl-amino]-4-acridinecarboxamide in rabbits
- 1 April 1986
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 16 (3) , 253-256
- https://doi.org/10.1007/bf00293987
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Determination of N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenylamino]-4-acridinecarboxamide in plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Elimination Kinetics of Amsacrine in the Rabbit: Evidence of NonlinearityPharmacology, 1985
- Effect of lipid solubility on hepatic first-pass metabolism of barbiturates in rabbitsInternational Journal of Pharmaceutics, 1984
- Volume Shifts and Protein Binding Estimates using Equilibrium Dialysis: Application to Prednisolone Binding in HumansJournal of Pharmaceutical Sciences, 1983
- High-performance liquid chromatographic method for the determination of 4′-(9-acridinylamino)methanesulfon-m-anisidide in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- M-AMSA in disseminated prostatic carcinoma: a phase II study.1982
- Disposition of Quinidine in the RabbitJournal of Pharmaceutical Sciences, 1982
- PHASE-II TRIAL OF META-AMSA IN HEPATOCELLULAR-CARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY1982
- PHASE-II TRIAL OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (AMSA) IN THE TREATMENT OF ADVANCED NON-HODGKINS LYMPHOMA1980
- The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) seriesPublished by Elsevier ,1974